Stallergenes Greer enters partnership to develop device and app

Stallergenes Greer and Aptar Pharma will collaborate to develop a new connected device with a companion app for patients going through treatment with the allergy company's allergen immunotherapy.
Photo: Joachim Adrian
Photo: Joachim Adrian
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN

The allergy company Stallergenes Greer has entered into a partnership with Aptar Pharma regarding the development of a novel connected device and a companion mobile app, the former reports in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading